The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Newest first

New topics page 23

Topics ordered by when they were created rather than by activity. This is where a question that nobody has answered yet is easiest to find — and answering one is the fastest route to a first solution badge.

1,535 topics · page 23 of 40

TopicParticipantsRepliesViewsActivity
EMA product information as a primary source
Posting this under the heading it deserves: EMA product information as a primary source Everything below is what sits behind that. Documenting an access outcome, dated, because everything in this category…
YISVCDAMB+70 74 7k 8mo
Follow-up: What a seizure notice actually says
What a seizure notice actually says — that is the question, and I have not found it answered plainly anywhere I have looked. Structured report rather than an opinion, following the format the maintainers…
BNSLIIIACA+35 41 490 9mo
Which panel is worth repeating and which is worth ignoring — a second dataset
Asking directly, because I could not find a straight answer: Which panel is worth repeating and which is worth ignoring — a second dataset General question, not a request for advice about my own care — I know…
VBPWCGDOTP+108 117 46k 4mo
Pharmaceutical compounding rules, summarised from primary sources — a second dataset
Posting this under the heading it deserves: Pharmaceutical compounding rules, summarised from primary sources — a second dataset Everything below is what sits behind that. A logistics question, since the…
CRDPICCDJB+50 56 780 8mo
Oral versus injectable exposure: comparing apples to a different fruit
Oral versus injectable exposure: comparing apples to a different fruit — setting out what I have, and where I think it stops being reliable. Comparing SURMOUNT-2 ( Lancet , 2023) with SURMOUNT-4 ( JAMA ,…
JMMBCBJNNM+19 23 332 8mo
Common supplements people ask about, assessed one at a time — a second dataset
Posting this under the heading it deserves: Common supplements people ask about, assessed one at a time — a second dataset Everything below is what sits behind that. Reporting something rather than asking…
VMJRCTDBTD+97 104 15k 3mo
Absolute versus relative contraindications
On the subject in the title: Absolute versus relative contraindications Working notes rather than a conclusion. General question, not a request for advice about my own care — I know the difference and I would…
HNBRMALFN+4 8 23k 8mo
A parcel stationary at a customs facility for nine days
On the subject in the title: A parcel stationary at a customs facility for nine days Working notes rather than a conclusion. A logistics question, since the answers here are usually better than anywhere else…
TVJSBSHMSL+64 72 51k 1mo
Turnaround times and what they mean for a decision
Turnaround times and what they mean for a decision Writing it up because I had to work it out twice and would rather nobody else did. A logistics question, since the answers here are usually better than…
TDONKPWTP 4 29k 3mo
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on
Posting this under the heading it deserves: SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Everything below is what sits behind that. Comparing SURPASS-2 ( N Engl J Med…
GOGTMMDSRM+122 136 48k 9mo
Payment mechanics and the recovery options that do not exist
Payment mechanics and the recovery options that do not exist Writing it up because I had to work it out twice and would rather nobody else did. I would like to talk about documentation quality as a signal,…
INDDNMFI+80 89 24k 9mo
Run-in periods and the population they select — the long version
Run-in periods and the population they select — the long version Writing it up because I had to work it out twice and would rather nobody else did. Session topic: SUSTAIN 6 ( N Engl J Med , 2016). Please read…
ALFREK 2 8.9k 4mo
A widely repeated interaction claim that turns out to be unsupported
On the subject in the title: A widely repeated interaction claim that turns out to be unsupported Working notes rather than a conclusion. Practical question with the units stated, because I have seen how…
NKRGBNMSDT+47 51 37k 3mo
Amylin receptor signalling and satiety
Amylin receptor signalling and satiety Writing it up because I had to work it out twice and would rather nobody else did. A documentation question rather than an analytical one. I have a certificate in front…
SGBCTNNATT+22 26 1.8k 9mo
Why "add 2 mL" is not an instruction
The question in the title: Why "add 2 mL" is not an instruction I will give what I have already checked below so nobody repeats it. A question about technique rather than about dose. I have been doing the…
MLBAIKKN+23 27 3.5k 6mo
The anatomy of a question that gets answered within an hour — the long version
The anatomy of a question that gets answered within an hour — the long version Writing it up because I had to work it out twice and would rather nobody else did. Question in the title. Context below, and I…
BCCDSBBDAR+129 142 49k 8mo
Price changes over 2025 and 2026, tabulated and dated — does this still hold?
Price changes over 2025 and 2026, tabulated and dated — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Documenting an access outcome, dated,…
WMCCDFKSDO+147 156 18k 3mo
Second pass at: I joined for one answer and stayed for a year — what changed my mind
Second pass at: I joined for one answer and stayed for a year — what changed my mind — setting out what I have, and where I think it stops being reliable. Question in the title. Context below, and I have…
NPDBJJFIL 4 25k 2mo
Sleep tracking data and its considerable limitations
Sleep tracking data and its considerable limitations — setting out what I have, and where I think it stops being reliable. Asking about a population rather than about a person. The published trials in this…
MEKBATRFCH+109 126 61k 9mo
[2026 update] What a good consultation looks like from the other side
The question in the title: What a good consultation looks like from the other side I will give what I have already checked below so nobody repeats it. Asking about a population rather than about a person. The…
GIJSATYAS+32 36 13k 1mo
Journal club: STEP 3 and the intensive behavioural therapy floor
Posting this under the heading it deserves: Journal club: STEP 3 and the intensive behavioural therapy floor Everything below is what sits behind that. Comparing SCALE ( N Engl J Med , 2015) with STEP 4 (…
LSDOJFPWCL+6 10 13k 28d
A 40-week log with the measurement method stated
On the subject in the title: A 40-week log with the measurement method stated Working notes rather than a conclusion. Longitudinal report with the method stated, because a number without a method is not a…
SMCRRSGPRN+87 97 18k 9mo
What happens after your first post: likes, trust levels, and why none of it matters much — what changed since
The question in the title: What happens after your first post: likes, trust levels, and why none of it matters much — what changed since I will give what I have already checked below so nobody repeats it. I…
LFNTMASPPO+105 118 57k 9mo
New subcategory: rationale and scope
On the subject in the title: New subcategory: rationale and scope Working notes rather than a conclusion. Process question about how this site works. I have read the guidelines and the trust-level page and I…
KVSFTENMH+126 138 13k 9mo
Alcohol: what is documented and what is folklore — the long version
Alcohol: what is documented and what is folklore — the long version — setting out what I have, and where I think it stops being reliable. Reporting something rather than asking about it, in case the pattern…
ADNISSZOPI+9 13 7.3k 6mo
Coverage in the US: a map of the usual obstacles
Coverage in the US: a map of the usual obstacles — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is what determines the…
GPMYASKHFA+46 50 7.9k 5mo
The 2.5 mg starting dose is not a therapeutic dose — why that matters — a second dataset
Posting this under the heading it deserves: The 2.5 mg starting dose is not a therapeutic dose — why that matters — a second dataset Everything below is what sits behind that. Session topic: STEP 8 ( JAMA ,…
FBSERSGRI+12 16 11k 7mo
Revisiting: Gallbladder disease risk with rapid weight loss
Revisiting: Gallbladder disease risk with rapid weight loss Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The…
BVSLN 2 2k 9mo
Early satiety becoming a problem rather than a benefit
Early satiety becoming a problem rather than a benefit — setting out what I have, and where I think it stops being reliable. A question about technique rather than about dose. I have been doing the same thing…
LCJMPYEST+20 24 2.5k 6mo
Is "synergy" the right word for the combination data?
Is "synergy" the right word for the combination data? — that is the question, and I have not found it answered plainly anywhere I have looked. Session topic: SCALE ( N Engl J Med , 2015). Please read it…
JSRASMNAKF+5 9 13k 25d